Sarcoidosis, Malignancy, and Immunosuppressive Therapy

Harold L. Israel, MD
Arch Intern Med. 1978;138(6):907-908. doi:10.1001/archinte.1978.03630310007006.
Text Size: A A A
Published online

Impairment of type IV cell-mediated hypersensitivity reactions have long been recognized as a characteristic of sarcoidosis, and decreased immunological surveillance would be expected to result in an increased occurrence of neoplasia. Evidence that this occurs has been difficult to accumulate, because sarcoidosis develops at an early age in most cases, and because prolonged observation of large numbers of patients with sarcoidosis is difficult. In Denmark, most cases of sarcoidosis and nearly all malignant tumors are reported to national registries. Brincker and Wilbek1 checked the files of both registries and found that, among 2,544 cases of sarcoidosis, with a mean age of 32 years, 48 patients had malignancy simultaneously with or after diagnosis of the sarcoidosis; substantially fewer, 33.8, would have been expected in the Danish general population of similar age and sex. The difference was accounted for entirely by increased numbers of lung cancer and malignant lymphoma, with no


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.